Menopause is a natural biological transition that every woman experiences, yet its effects on emotional well-being, cognitive function, and brain health are still widely misunderstood. For many women, menopause is not only about hot flashes and physical changes. It can also involve shifts in mood, sleep, memory, and overall mental health that significantly affect quality of life.
In recent years, hormone replacement therapy, commonly known as HRT, has become more widely prescribed to help manage menopausal symptoms. In England alone, the percentage of women using HRT rose from 11 percent in 2021 to around 15 percent in 2023. While HRT is effective for relieving vasomotor symptoms such as hot flashes and night sweats, its psychological and cognitive effects remain a subject of debate.
A major new study published online by Cambridge University Press on 27 January 2026 provides important insights into how menopause and HRT are linked to mental health, cognition, and brain structure. Drawing on data from nearly 125,000 women in the UK Biobank, this research offers one of the most comprehensive examinations to date of the emotional and cognitive effects of menopause and hormone replacement therapy.
This article explores the key findings of that study, explains what they mean in practical terms, and discusses why menopause deserves far more attention as a mental health issue.
Menopause marks the end of a woman’s reproductive years and is defined by the cessation of menstrual periods for 12 consecutive months. The transition into menopause is driven by declining levels of ovarian hormones, particularly estrogen and progesterone. These hormones play an important role not only in reproductive health but also in brain function.
Estrogen receptors are found throughout the brain, including areas involved in memory, emotional regulation, and sleep. As hormone levels fluctuate and eventually decline during menopause, many women report symptoms such as low mood, anxiety, irritability, brain fog, forgetfulness, and insomnia. Despite how common these symptoms are, they have often been dismissed or under-researched.
Hormone replacement therapy aims to replenish declining hormone levels and is widely recommended for physical menopausal symptoms. However, whether HRT protects mental health or cognitive function has remained unclear.
The 2026 study titled Emotional and cognitive effects of menopause and hormone replacement therapy was conducted by an international research team led by Katharina Zuhlsdorff and colleagues. It was published in the journal Psychological Medicine and is available as an open access article.
Researchers analyzed data from 124,780 women in the UK Biobank, a large population study that includes health questionnaires, cognitive tests, and brain imaging. Participants were divided into three groups:
The study examined multiple outcomes, including anxiety, depression, sleep problems, cognitive performance, and brain structure. A subset of over 10,000 women also underwent MRI scans, allowing researchers to examine gray matter volumes in key brain regions.
One of the clearest findings from the study was that menopause is associated with poorer mental health outcomes.
Compared with pre-menopausal women, post-menopausal women reported higher levels of anxiety, depression, and psychological distress. They were more likely to report having seen a general practitioner or psychiatrist for mental health concerns and were more likely to have clinical diagnoses of anxiety or recurrent depression.
These findings reinforce what many women report anecdotally: menopause can be an emotionally challenging period, not just a physical one.
Interestingly, the study found that post-menopausal women using HRT reported even higher levels of anxiety and depression than post-menopausal women who were not using HRT.
At first glance, this might suggest that HRT worsens mental health. However, the researchers conducted additional analyses to better understand this pattern. Their post-hoc analysis showed that women who later went on to use HRT already had higher levels of anxiety and depression before starting treatment.
This suggests that women with pre-existing mental health symptoms may be more likely to seek medical help and be prescribed HRT. In other words, the higher rates of depression and anxiety in the HRT group may reflect baseline differences rather than harmful effects of the therapy itself.
This finding is important because it highlights the complexity of interpreting observational data. It also underscores the need for clinicians to consider mental health history when discussing HRT with patients.
Sleep disturbances are among the most common and distressing symptoms reported during menopause. This study confirmed that post-menopausal women experience more insomnia, greater tiredness, and shorter sleep duration than pre-menopausal women.
Both post-menopausal groups showed worse sleep outcomes, regardless of HRT use. Women using HRT reported particularly high levels of tiredness, although sleep duration did not significantly differ between HRT users and non-users.
These findings suggest that while HRT may help some women with sleep problems related to hot flashes, it does not fully address the broader sleep disturbances associated with menopause. Poor sleep, in turn, is closely linked to mood disorders, cognitive complaints, and reduced quality of life.
Many women worry about memory problems and cognitive decline during menopause. The good news from this study is that objective cognitive performance showed only modest differences between groups.
Researchers assessed memory, attention, and processing speed using standardized touchscreen tasks. Overall, there were no meaningful differences in memory performance between pre-menopausal women and post-menopausal women, regardless of HRT use.
Processing speed was slightly slower in post-menopausal women who were not using HRT compared with pre-menopausal women. However, this difference was small and not observed consistently across all cognitive measures.
These findings suggest that while women may subjectively experience cognitive difficulties during menopause, measurable declines in basic cognitive performance are limited, at least in midlife.
One of the most novel aspects of this study was its use of brain imaging to examine structural changes associated with menopause and HRT.
The researchers focused on gray matter volumes in three brain regions:
Post-menopausal women showed smaller gray matter volumes in all three regions compared with pre-menopausal women. These reductions were most pronounced in women using HRT.
Reduced gray matter volume does not necessarily mean irreversible damage. Brain structure naturally changes with age, and volume differences can reflect many factors. However, these regions are closely linked to mood, sleep, and emotional processing, which aligns with the mental health findings of the study.
Importantly, all analyses controlled for age, body mass index, education, income, smoking status, and history of depression, strengthening confidence in the results.
Taken together, this large-scale study suggests several key conclusions:
These findings do not mean that HRT is ineffective or harmful. HRT remains an evidence-based treatment for physical menopausal symptoms and can improve quality of life for many women. However, it highlights that HRT alone is not a comprehensive solution for emotional and psychological symptoms.
This research emphasizes the need to take menopausal mental health seriously. Anxiety, depression, and sleep disturbances should not be viewed as secondary or inevitable issues.
Healthcare providers should:
For women, these findings validate lived experiences. Feeling emotionally different during menopause is not a personal failing or a sign of weakness. It reflects real biological and neurological changes.
Despite affecting half the population, menopause remains under-represented in mental health research. This study highlights an unmet need for better education, targeted interventions, and integrated care models that address both physical and psychological symptoms.
Future research should explore how different types of HRT, timing of treatment, genetics, and pre-existing mental health conditions influence outcomes. Longitudinal studies will be particularly important to clarify cause and effect.
Menopause is a profound life transition that extends far beyond reproductive health. The emotional and cognitive effects are real, measurable, and deserving of attention. While hormone replacement therapy can be an important part of symptom management, it is not a universal fix for mental health challenges.
This landmark study provides valuable clarity and underscores a simple truth: supporting women through menopause requires a holistic approach that includes mental health care, education, and compassion.
Zuhlsdorff, K., Langley, C., Bethlehem, R., Warrier, V., Romero Garcia, R., & Sahakian, B. J. (2026). Emotional and cognitive effects of menopause and hormone replacement therapy. Psychological Medicine, Volume 56, e24. Published by Cambridge University Press. DOI: 10.1017/S0033291725102845
This article is for informational and educational purposes only. It does not constitute medical advice and should not be used as a substitute for professional diagnosis or treatment. Always seek the advice of a qualified healthcare provider with any questions regarding menopause, hormone replacement therapy, or mental health.
Most Accurate Healthcare AI designed for everything from admin workflows to clinical decision support.